| 1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]- |
无中文名称 |
1420071-30-2 |
| WS6 |
WS6 |
1421227-53-3 |
| Osimertinib mesylate |
AZD9291(甲磺酸盐) |
1421373-66-1 |
| N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine |
AZD9291中间体2 |
1421372-94-2 |
| Mutant EGFR inhibitor |
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 |
1421373-62-7 |
| Mutated EGFR-IN-1 |
AZD9291中间体1 |
1421372-66-8 |
| AZ-5104 |
奥西替尼中间体 |
1421373-98-9 |
| 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro- |
AZD9291中间体3 |
1421372-67-9 |
| Doxercalciferol-D3 |
度骨化醇-D3 |
1217448-46-8 |
| PFI-1 |
PFI-1 (PF-6405761) |
1403764-72-6 |
| Nexturastat A |
4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE |
1403783-31-2 |
| 8-fluoro-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one |
8-氟-1,3,4,5-四氢-2-[4-[(甲基氨基)甲基]苯基]-6H-吡咯并[4,3,2-EF][2]苯并氮杂-6-酮 |
1408282-26-7 |
| Acetylene-linker-Val-Cit-PABC-MMAE |
1411977-95-1 |
1411977-95-1 |
| Saphris hydrochloride |
阿塞那平盐酸盐 |
1412458-61-7 |
| Benzeneacetic acid, 2,5-dibromo-, 3-bromophenyl ester |
2-(2,5-二溴苯基)乙酸3-溴苯酯 |
1403991-82-1 |
| 1-(4-bromo-2-hydroxyphenyl)-2-(2,5-dibromophenyl)ethan-1-one |
1-(4-溴-2-羟基苯基)-2-(2,5-二溴苯基)乙烷-1-酮 |
1403991-85-4 |
| CCT 244747 |
3-[(1R)-2-(二甲基氨基)-1-甲基乙氧基]-5-[[4-甲氧基-5-(1-甲基-1H-吡唑-4-基)-2-吡啶基]氨基]-2-吡嗪甲腈 |
1404095-34-6 |
| RGFP 109 |
RG2833(RGFP109) |
1215493-56-3 |
| ML281 |
ML281 |
1404437-62-2 |
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
